Stay updated on ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM
Sign up to get notified when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.

Latest updates to the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows a 403 Forbidden error, with navigation limited to a Home link and revision header. Several study documents and sections (such as PDFs, protocols, and results) appear to have been removed, reducing access to study materials.SummaryDifference21%

- Check29 days agoChange DetectedThe page's core disease references and a related topics/resources section were removed, eliminating explicit mentions of multiple myeloma and genetics-related resources within the study context.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page, reflecting a small platform update. This change does not appear to affect study details or user actions.SummaryDifference0.0%

- Check50 days agoChange DetectedReplaces the error page with the full study details page, adding access to documents (IPD plan, protocol, SAP) and listing the study locations across 16 sites. This change turns the page from an unavailable state into a content-rich trial record.SummaryDifference74%

- Check57 days agoChange DetectedThe page now displays the revision tag updated to v3.6.5, replacing the previous v3.6.4. This indicates a minor platform update and does not alter the study details presented on the page.SummaryDifference0.0%

- Check71 days agoChange DetectedThis change updates the site's release version from v3.6.3 to v3.6.4, indicating a software update to the ClinicalTrials.gov interface. It does not modify any study data or page content.SummaryDifference0.0%

Stay in the know with updates to ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM
Enter your email address, and we'll notify you when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.